CLPT
ClearPoint Neuro, Inc.
NASDAQ · Healthcare · Medical - Devices · US
$9.17
+1.10%Oct 14, 2026, 20:05 UTC
ClearPoint Neuro announced that it will release its third-quarter 2026 financial results after the market close on October 28, 2026.
Source:Sep 24, 2026, 06:01 UTC
Julier Medical appointed Will Martin as President and Chief Executive Officer.
Source:Aug 5, 2026, 07:09 UTC
ClearPoint Neuro reported second-quarter 2026 revenue of $10.9 million, up 18% from $9.2 million in the prior-year period.
Source:Aug 3, 2026, 20:05 UTC
ClearPoint Neuro reported second quarter 2026 revenue of $10.9 million, an 18% increase year-over-year, with biologics and drug delivery revenue declining 15% due to fewer products shipped to biopharma customers for new trial initiations.